, Will stock surge before Earnings results? NASDAQ:BLKB, NASDAQ:OCX, NYSE:BC, NASDAQ:ANIK

0
8
Calculator, Currency, Financial Figures, Number, Document

BLACKBAUD (NASDAQ:BLKB) EARNINGS INFORMATION (NASDAQ:BLKB)

Blackbaud last issued its quarterly earnings results on July 29th, 2020. The technology company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.35. The business had revenue of $231.99 million for the quarter, compared to analyst estimates of $217.74 million. Its revenue was up 2.8% on a year-over-year basis. Blackbaud has generated $1.27 earnings per share over the last year and currently has a price-to-earnings ratio of 136.0. Blackbaud has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, October 26th, 2020 based off prior year’s report dates.

HOW HAS BLACKBAUD’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NASDAQ:BLKB)

Blackbaud’s stock was trading at $61.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BLKB shares have increased by 2.4% and is now trading at $62.54.

ONCOCYTE (NASDAQ:OCX) EARNINGS INFORMATION (NASDAQ:OCX)

OncoCyte last posted its earnings results on May 12th, 2020. The reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by $0.02. The company earned $0.02 million during the quarter. OncoCyte has generated $0.00 earnings per share over the last year.

HOW HAS ONCOCYTE’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NASDAQ:OCX)

OncoCyte’s stock was trading at $2.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, OCX stock has decreased by 36.9% and is now trading at $1.35.

BRUNSWICK (NYSE:BC) EARNINGS INFORMATION (NYSE:BC)

Brunswick last released its earnings results on July 30th, 2020. The reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.54. The business earned $987.80 million during the quarter, compared to analysts’ expectations of $801.62 million. Its quarterly revenue was down 15.2% compared to the same quarter last year. Brunswick has generated $4.33 earnings per share over the last year.

HOW HAS BRUNSWICK’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:BC)

Brunswick’s stock was trading at $41.76 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BC shares have increased by 60.4% and is now trading at $66.98.

ANIKA THERAPEUTICS (NASDAQ:ANIK) EARNINGS INFORMATION (NASDAQ:ANIK)

Anika Therapeutics last issued its quarterly earnings results on July 30th, 2020. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.33. The company had revenue of $30.68 million for the quarter, compared to the consensus estimate of $16.73 million. Anika Therapeutics has generated $2.05 earnings per share over the last year and currently has a price-to-earnings ratio of 58.7.

HOW HAS ANIKA THERAPEUTICS’ STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NASDAQ:ANIK)

Anika Therapeutics’ stock was trading at $36.39 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ANIK shares have increased by 0.0% and is now trading at $36.40.